1 Study Coverage
1.1 Prostate Cancer Medicine Revenue in Prostate Cancer Medicine Business (2017-2022) & (US$ Million) Introduction
1.2 Global Prostate Cancer Medicine Outlook 2017 VS 2022 VS 2028
1.2.1 Global Prostate Cancer Medicine Market Size for the Year 2017-2028
1.2.2 Global Prostate Cancer Medicine Market Size for the Year 2017-2028
1.3 Prostate Cancer Medicine Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.3.1 The Market Share of United States Prostate Cancer Medicine in Global, 2017 VS 2022 VS 2028
1.3.2 The Growth Rate of Prostate Cancer Medicine Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4 Prostate Cancer Medicine Market Dynamics
1.4.1 Prostate Cancer Medicine Industry Trends
1.4.2 Prostate Cancer Medicine Market Drivers
1.4.3 Prostate Cancer Medicine Market Challenges
1.4.4 Prostate Cancer Medicine Market Restraints
1.5 Study Objectives
1.6 Years Considered
2 Prostate Cancer Medicine by Type
2.1 Prostate Cancer Medicine Market Segment by Type
2.1.1 LHRH Antagonists
2.1.2 LHRH Analogs
2.1.3 Antiandrogens
2.1.4 Pipeline Drugs for Hormonal Therapy
2.2 Global Prostate Cancer Medicine Market Size by Type (2017, 2022 & 2028)
2.3 Global Prostate Cancer Medicine Market Size by Type (2017-2028)
2.4 United States Prostate Cancer Medicine Market Size by Type (2017, 2022 & 2028)
2.5 United States Prostate Cancer Medicine Market Size by Type (2017-2028)
3 Prostate Cancer Medicine by Application
3.1 Prostate Cancer Medicine Market Segment by Application
3.1.1 Age Below 55
3.1.2 Age 55-75
3.1.3 Age Above 75
3.2 Global Prostate Cancer Medicine Market Size by Application (2017, 2022 & 2028)
3.3 Global Prostate Cancer Medicine Market Size by Application (2017-2028)
3.4 United States Prostate Cancer Medicine Market Size by Application (2017, 2022 & 2028)
3.5 United States Prostate Cancer Medicine Market Size by Application (2017-2028)
4 Global Prostate Cancer Medicine Competitor Landscape by Company
4.1 Global Prostate Cancer Medicine Market Size by Company
4.1.1 Top Global Prostate Cancer Medicine Companies Ranked by Revenue (2021)
4.1.2 Global Prostate Cancer Medicine Revenue by Player (2017-2022)
4.2 Global Prostate Cancer Medicine Concentration Ratio (CR)
4.2.1 Prostate Cancer Medicine Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Companies of Prostate Cancer Medicine in 2021
4.2.3 Global Prostate Cancer Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Prostate Cancer Medicine Headquarters, Revenue in Prostate Cancer Medicine Business (2017-2022) & (US$ Million) Type
4.3.1 Global Prostate Cancer Medicine Headquarters and Area Served
4.3.2 Global Prostate Cancer Medicine Companies Revenue in Prostate Cancer Medicine Business (2017-2022) & (US$ Million) Type
4.3.3 Date of International Companies Enter into Prostate Cancer Medicine Market
4.4 Companies Mergers & Acquisitions, Expansion Plans
4.5 United States Prostate Cancer Medicine Market Size by Company
4.5.1 Top Prostate Cancer Medicine Players in United States, Ranked by Revenue (2021)
4.5.2 United States Prostate Cancer Medicine Revenue by Players (2020, 2021 & 2022)
5 Global Prostate Cancer Medicine Market Size by Region
5.1 Global Prostate Cancer Medicine Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Prostate Cancer Medicine Market Size by Region (2017-2028)
5.2.1 Global Prostate Cancer Medicine Market Size by Region: 2017-2022
5.2.2 Global Prostate Cancer Medicine Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Prostate Cancer Medicine Market Size YoY Growth 2017-2028
6.1.2 North America Prostate Cancer Medicine Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Prostate Cancer Medicine Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Prostate Cancer Medicine Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Prostate Cancer Medicine Market Size YoY Growth 2017-2028
6.3.2 Europe Prostate Cancer Medicine Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Prostate Cancer Medicine Market Size YoY Growth 2017-2028
6.4.2 Latin America Prostate Cancer Medicine Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Prostate Cancer Medicine Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Prostate Cancer Medicine Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 U.A.E
7 Company Profiles
7.1 AstraZeneca plc
7.1.1 AstraZeneca plc Company Details
7.1.2 AstraZeneca plc Business Overview
7.1.3 AstraZeneca plc Prostate Cancer Medicine Introduction
7.1.4 AstraZeneca plc Revenue in Prostate Cancer Medicine Business (2017-2022)
7.1.5 AstraZeneca plc Recent Development
7.2 Active Biotech
7.2.1 Active Biotech Company Details
7.2.2 Active Biotech Business Overview
7.2.3 Active Biotech Prostate Cancer Medicine Introduction
7.2.4 Active Biotech Revenue in Prostate Cancer Medicine Business (2017-2022)
7.2.5 Active Biotech Recent Development
7.3 Bristol Myers-Squibb
7.3.1 Bristol Myers-Squibb Company Details
7.3.2 Bristol Myers-Squibb Business Overview
7.3.3 Bristol Myers-Squibb Prostate Cancer Medicine Introduction
7.3.4 Bristol Myers-Squibb Revenue in Prostate Cancer Medicine Business (2017-2022)
7.3.5 Bristol Myers-Squibb Recent Development
7.4 Teva Pharmaceuticals Industries Ltd.
7.4.1 Teva Pharmaceuticals Industries Ltd. Company Details
7.4.2 Teva Pharmaceuticals Industries Ltd. Business Overview
7.4.3 Teva Pharmaceuticals Industries Ltd. Prostate Cancer Medicine Introduction
7.4.4 Teva Pharmaceuticals Industries Ltd. Revenue in Prostate Cancer Medicine Business (2017-2022)
7.4.5 Teva Pharmaceuticals Industries Ltd. Recent Development
7.5 Johnson & Johnson
7.5.1 Johnson & Johnson Company Details
7.5.2 Johnson & Johnson Business Overview
7.5.3 Johnson & Johnson Prostate Cancer Medicine Introduction
7.5.4 Johnson & Johnson Revenue in Prostate Cancer Medicine Business (2017-2022)
7.5.5 Johnson & Johnson Recent Development
7.6 Pfizer Inc.
7.6.1 Pfizer Inc. Company Details
7.6.2 Pfizer Inc. Business Overview
7.6.3 Pfizer Inc. Prostate Cancer Medicine Introduction
7.6.4 Pfizer Inc. Revenue in Prostate Cancer Medicine Business (2017-2022)
7.6.5 Pfizer Inc. Recent Development
7.7 Bayer AG
7.7.1 Bayer AG Company Details
7.7.2 Bayer AG Business Overview
7.7.3 Bayer AG Prostate Cancer Medicine Introduction
7.7.4 Bayer AG Revenue in Prostate Cancer Medicine Business (2017-2022)
7.7.5 Bayer AG Recent Development
7.8 Abbott Laboratories
7.8.1 Abbott Laboratories Company Details
7.8.2 Abbott Laboratories Business Overview
7.8.3 Abbott Laboratories Prostate Cancer Medicine Introduction
7.8.4 Abbott Laboratories Revenue in Prostate Cancer Medicine Business (2017-2022)
7.8.5 Abbott Laboratories Recent Development
7.9 Astellas Pharma Inc.
7.9.1 Astellas Pharma Inc. Company Details
7.9.2 Astellas Pharma Inc. Business Overview
7.9.3 Astellas Pharma Inc. Prostate Cancer Medicine Introduction
7.9.4 Astellas Pharma Inc. Revenue in Prostate Cancer Medicine Business (2017-2022)
7.9.5 Astellas Pharma Inc. Recent Development
7.10 Roche Holding AG
7.10.1 Roche Holding AG Company Details
7.10.2 Roche Holding AG Business Overview
7.10.3 Roche Holding AG Prostate Cancer Medicine Introduction
7.10.4 Roche Holding AG Revenue in Prostate Cancer Medicine Business (2017-2022)
7.10.5 Roche Holding AG Recent Development
8 Research Findings and Conclusion
9 Appendix
9.1 Research Methodology
9.1.1 Methodology/Research Approach
9.1.2 Data Source
9.2 Author Details
9.3 Disclaimer
